Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Increased alcohol dehydrogenase 1 activity promotes longevity.

Current biology : CB | 2023

Several molecules can extend healthspan and lifespan across organisms. However, most are upstream signaling hubs or transcription factors orchestrating complex anti-aging programs. Therefore, these molecules point to but do not reveal the fundamental mechanisms driving longevity. Instead, downstream effectors that are necessary and sufficient to promote longevity across conditions or organisms may reveal the fundamental anti-aging drivers. Toward this goal, we searched for effectors acting downstream of the transcription factor EB (TFEB), known as HLH-30 in C. elegans, because TFEB/HLH-30 is necessary across anti-aging interventions and its overexpression is sufficient to extend C. elegans lifespan and reduce biomarkers of aging in mammals including humans. As a result, we present an alcohol-dehydrogenase-mediated anti-aging response (AMAR) that is essential for C. elegans longevity driven by HLH-30 overexpression, caloric restriction, mTOR inhibition, and insulin-signaling deficiency. The sole overexpression of ADH-1 is sufficient to activate AMAR, which extends healthspan and lifespan by reducing the levels of glycerol-an age-associated and aging-promoting alcohol. Adh1 overexpression is also sufficient to promote longevity in yeast, and adh-1 orthologs are induced in calorically restricted mice and humans, hinting at ADH-1 acting as an anti-aging effector across phyla.

Pubmed ID: 36805847 RIS Download

Associated grants

  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007267
  • Agency: NIH HHS, United States
    Id: P40 OD010440
  • Agency: NIA NIH HHS, United States
    Id: F30 AG067760
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM127394
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM075240
  • Agency: NIDDK NIH HHS, United States
    Id: R00 DK087928
  • Agency: NIDDK NIH HHS, United States
    Id: K99 DK087928
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM008136

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Rabbit Anti-Rat IgG - H&L Polyclonal Antibody, HRP Conjugated (antibody)

RRID:AB_955450

This polyclonal targets Rat Rat IgG secondary - H&L

View all literature mentions

Anti-Rabbit IgG (H+L), HRP Conjugate (antibody)

RRID:AB_430833

This polyclonal secondary targets IgG (H+L)

View all literature mentions

IRDye 800CW Goat anti-Rabbit IgG (antibody)

RRID:AB_621843

This polyclonal secondary targets IgG

View all literature mentions

alpha Tubulin Monoclonal Antibody (YL1/2) (antibody)

RRID:AB_2210201

This monoclonal targets alpha Tubulin

View all literature mentions

4A1 anti-pan-alpha tubulin (antibody)

RRID:AB_2732839

This monoclonal targets pan-alpha tubulin

View all literature mentions

Rabbit Anti-Rat IgG - H&L Polyclonal Antibody, HRP Conjugated (antibody)

RRID:AB_955450

This polyclonal targets Rat Rat IgG secondary - H&L

View all literature mentions

Anti-Rabbit IgG (H+L), HRP Conjugate (antibody)

RRID:AB_430833

This polyclonal secondary targets IgG (H+L)

View all literature mentions